Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.
about
The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and AutoimmunityNovel immunotherapies for hematologic malignanciesTrial watch: IDO inhibitors in cancer therapyCytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNAIndoleamine 2,3 dioxygenase in intestinal diseaseAttenuation of pathogenic immune responses during infection with human and simian immunodeficiency virus (HIV/SIV) by the tetracycline derivative minocyclineOn watching the watchers: IDO and type I/II IFNAryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanismIndoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethalityVirus Infections Incite Pain Hypersensitivity by Inducing Indoleamine 2,3 DioxygenaseRecent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: Potential ways to control these functionsB-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm.Development of murine lupus involves the combined genetic contribution of the SLAM and FcgammaR intervals within the Nba2 autoimmune susceptibility locus.Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice.Activation of the STING adaptor attenuates experimental autoimmune encephalitis.B-lymphoid cells with attributes of dendritic cells regulate T cells via indoleamine 2,3-dioxygenaseAcute alcohol intake induces SOCS1 and SOCS3 and inhibits cytokine-induced STAT1 and STAT3 signaling in human monocytesProtEx technology for the generation of novel therapeutic cancer vaccinesInhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists.Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.Systemic treatment with CpG-B after sublethal rickettsial infection induces mouse death through indoleamine 2,3-dioxygenase (IDO).Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environmentIDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation.Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancerTargeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds.The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.Leishmania major attenuates host immunity by stimulating local indoleamine 2,3-dioxygenase expression.Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infectionBlockade of programmed death-1 pathway rescues the effector function of tumor-infiltrating T cells and enhances the antitumor efficacy of lentivector immunization.Immune dysregulation by the rheumatoid arthritis shared epitope.A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity.Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapyHaemophilus ducreyi lipooligosaccharides induce expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase via type I interferons and tumor necrosis factor alpha in human dendritic cells.The role of indoleamine 2,3 dioxygenase in beneficial effects of stem cells in hind limb ischemia reperfusion injury.Fludarabine downregulates indoleamine 2,3-dioxygenase in tumors via a proteasome-mediated degradation mechanism.Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts.Plasmacytoid dendritic cells and the control of herpesvirus infections.
P2860
Q26785900-AC27F977-FAB3-4363-BA0B-92265880411FQ27004436-21D219F1-D078-4413-AC29-BF40800EB0B9Q27006866-172497CD-AD8C-4D35-8C1C-A97278747237Q27022855-0473D847-C093-4C0B-B81E-EF44AC312520Q27025063-8A582451-C948-4B87-8CCE-0A07FD58322BQ27342233-90DBEF4F-CE9B-4EDA-A887-54FF17A00FE0Q28295567-043159A3-54C3-4B01-80DA-8FB9353CFBDCQ28297392-714AE44F-0833-4B69-80D7-673CE435C4D3Q28509235-2CB19B03-C8F7-4C2D-A387-A65C4D60C3DFQ28551939-067B01C0-9FFD-47F8-9FA1-FA2037FEBBF8Q30252210-9DC0EDF1-79A4-42B9-898B-465F205C5C1FQ30275599-7BCC9CD4-1C0F-4F80-BD92-32ABE5402F41Q30433488-8C2D6891-52A7-4103-AA2A-658EBDBE83BCQ33519555-2C3AC66E-BEC7-4091-8E37-D068BB2B7B37Q33861332-2BF30EA4-476F-463D-BACE-209FE5748AC0Q33934819-8C7F7FFA-325F-44B1-8DC4-45A8E8CE2902Q33977596-84F9F9D3-5DA3-4A4D-BB72-8AD1DC2F11C9Q34048819-B739E146-7C73-4450-9C61-049EF74A962DQ34083495-1DCEA5DA-5BAC-43FF-BADD-09CD17715677Q34154099-F981A311-24C4-45BC-89FE-225A02B495DAQ34217664-3B8EB177-2F57-4314-AFAA-0FCF21B47059Q34242591-3C786E63-2BA8-4B6E-9E33-DA34EC0CD8FEQ34396547-2AEFA9E9-EC05-4FEE-84AF-48D64AF2563AQ34414152-CF562509-EDBB-46D5-816F-B2C162CCC890Q34550440-1B4CFA76-82D6-4CC8-8ABC-23BEF3782A5CQ34616168-ECD20F58-781D-4059-A4DF-A8376EFE8D19Q34657284-37BE5D72-4769-4F35-83C2-6252074FAC5EQ34657500-AFC608B9-9A9A-4912-9BF4-897F3DA875ECQ34681856-69CA041A-1ECE-4E13-8A82-57E5577B8A2BQ34772767-C7410704-A932-4ECB-A6DD-E8F7FB83C02DQ34778943-F04A98BE-34AE-46B1-B4E4-3783F1C4AAD3Q34801069-CADD31B5-9FAC-4536-A084-82D045C87986Q35037009-19D85E07-C4D6-4D4E-99E6-877B622ACDB6Q35106344-AB30DD23-81FE-4926-A5B3-22AD863F2FFFQ35119800-B111635E-5419-442D-B206-EDFA4001D98CQ35139241-0D1A7592-A12A-4945-9780-386B7BF54321Q35154150-3C1B987D-4F4A-4210-9C1E-83E3EAD9F782Q35184110-D7A9B10A-858D-4C62-A901-29C77D229490Q35216385-6038721B-4D42-4CDD-B3D4-3F90D2B2A92CQ35259804-4DC88D7F-3605-4A50-B378-527CBD496FEC
P2860
Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Cutting edge: CpG oligonucleot ...... ions via IFN Type 1 signaling.
@en
type
label
Cutting edge: CpG oligonucleot ...... ions via IFN Type 1 signaling.
@en
prefLabel
Cutting edge: CpG oligonucleot ...... ions via IFN Type 1 signaling.
@en
P2093
P1476
Cutting edge: CpG oligonucleot ...... ions via IFN Type 1 signaling.
@en
P2093
Andrew L Mellor
Anna Manlapat
Babak Baban
David H Munn
David J Kahler
Phillip R Chandler
P304
P356
10.4049/JIMMUNOL.175.9.5601
P407
P577
2005-11-01T00:00:00Z